A dual role for the API2 moiety in API2-MALT1-dependent NF-κB activation: Heterotypic oligomerization and TRAF2 recruitment

Oncogene

Volumn 26, Issue 38, 2007, Pages 5643-5654

  Lucas, P C ^a   Kuffa, P ^a   Gu, S ^a   Kohrt, D ^a   Kim, D S L ^a   Siu, K ^a   Jin, X ^a   Swenson, J ^a   McAllister Lucas, L M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

cIAP2; MALT lymphoma; MALT1; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MUTATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STIMULATION;

BLOTTING, WESTERN; CELL LINE; DIMERIZATION; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; IMMUNOPRECIPITATION; INHIBITOR OF APOPTOSIS PROTEINS; LUCIFERASES; MUTATION; NF-KAPPA B; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TACROLIMUS; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSFECTION;

EID: 34547955180     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210342     Document Type: Article

References (47)

1. Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H et al. (1999). A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18: 5785-5794.
2. Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V et al. (2006). Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Cancer Res 66: 5270-5277.
3. Bishop GA. (2004). The multifaceted roles of TRAFs in the regulation of B-cell function. Nat Rev Immunol 4: 775-786.
4. Deveraux QL, Reed JC. (1999). IAP family proteins - suppressors of apoptosis. Genes Dev 13: 239-252.
5. Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK et al. (1999). The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6 associated with mucosa-associated lymphoid tissue lymphomas. Blood 93: 3601-3609.
6. Dong W, Liu Y, Peng J, Chen L, Zou T, Xiao H et al. (2006). The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappa B from toll-like receptor 4. J Biol Chem 281: 26029-26040.
7. Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P et al. (2005). MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 105: 2891-2899.
8. Hosokawa Y, Suzuki H, Suzuki Y, Takahashi R, Seto M. (2004). Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma. Cancer Res 64: 3452-3457.
9. Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA. (2003). Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J Biol Chem 278: 45382-45390.
10. Hu S, Du MQ, Park SM, Alcivar A, Qu L, Gupta S et al. (2006). cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J Clin Invest 116: 174-181.
11. Inagaki H, Nakamura T, Li C, Sugiyama T, Asaka M, Kodaira J et al. (2004). Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 28: 1560-1567.
12. Isaacson PG. (1999). Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 36: 139-147.
13. Isaacson PG, Du MQ. (2004). MALT lymphoma: from morphology to molecules. Nat Rev Cancer 4: 644-653.
14. Iwano M, Okazaki K, Uchida K, Nakase H, Ohana M, Matsushima Y et al. (2004). Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs. J Gastroenterol 39: 739-746.
15. Levy M, Copie-Bergman C, Gameiro C, Chaumette MT, Delfau-Larue MH, Haioun C et al. (2005). Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 23: 5061-5066.
16. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y et al. (2001a). Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357: 39-40.
17. Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I et al. (2001b). T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 98: 1182-1187.
18. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C et al. (2002). T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122: 1286-1294.
19. Lucas PC, McAllister-Lucas LM, Nunez G. (2004). NF-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci 117: 31-39.
20. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF et al. (2001). Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 276: 19012-19019.
21. Luque LE, Grape KP, Junker M. (2002). A highly conserved arginine is critical for the functional folding of inhibitor of apoptosis (IAP) BIR domains. Biochemistry 41: 13663-13671.
22. McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, Benito A, Li Q et al. (2001). Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem 276: 30589-30597.
23. Morgan JA, Yin Y, Borowsky AD, Kuo F, Nourmand N, Koontz JI et al. (1999). Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 59: 6205-6213.
24. Murga Penas EM, Hinz K, Roser K, Copie-Bergman C, Wlodarska I, Marynen P et al. (2003). Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia 17: 2225-2229.
25. Okabe M, Inagaki H, Ohshima K, Yoshino T, Li C, Eimoto T et al. (2003). API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 162: 1113-1122.
26. Remstein ED, James CD, Kurtin PJ. (2000). Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 156: 1183-1188.
27. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. (1995). The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-1252.
28. Ruland J, Duncan GS, Wakeham A, Mak TW. (2003). Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19: 749-758.
29. Sakugawa ST, Yoshino T, Nakamura S, Inagaki H, Sadahira Y, Nakamine H et al. (2003). API2-MALT1 fusion gene in colorectal lymphoma. Mod Pathol 16: 1232-1241.
30. Salvesen GS, Duckett CS. (2002). IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3: 401-410.
31. Samuel T, Welsh K, Lober T, Togo SH, Zapata JM, Reed JC. (2006). Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J Biol Chem 281: 1080-1090.
32. Senyuk V, Li D, Zakharov A, Mikhail FM, Nucifora G. (2005). The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro. Cancer Res 65: 7603-7611.
33. So CW, Cleary ML. (2004). Dimerization: a versatile switch for oncogenesis. Blood 104: 919-922.
34. Stoffel A, Chaurushiya M, Singh B, Levine AJ. (2004). Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis. Proc Natl Acad Sci USA 101: 9079-9084.
35. Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G et al. (2003). T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101: 2335-2339.
36. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. (2004). The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 14: 289-301.
37. Turner SD, Alexander DR. (2006). Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. Leukemia 20: 572-582.
38. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV et al. (2000). Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6: 961-967.
39. Varfolomeev E, Wayson SM, Dixit VM, Fairbrother WJ, Vucic D. (2006). The inhibitor of apoptosis protein fusion c-IAP2/MALT1 stimulates NF-kappa B activation independently of TRAF1 and TRAF2. J Biol Chem 281: 29022-29029.
40. Wang D, You Y, Case SM, McAllister-Lucas LM, Wang L, DiStefano PS et al. (2002). A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol 3: 830-835.
41. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M et al. (1999). Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96: 35-45.
42. Wright CW, Duckett CS. (2005). Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function. J Clin Invest 115: 2673-2678.
43. Ye H, Liu H, Raderer M, Chott A, Ruskone-Fourmestraux A, Wotherspoon A et al. (2003). High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 101: 2547-2550.
44. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L et al. (1999). Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22: 63-68.
45. Zhou H, Du MQ, Dixit VM. (2005). Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7: 425-431.
46. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M et al. (2004). Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427: 167-171.
47. Zucca E, Bertoni F, Roggero E, Cavalli F. (2000). The gastric marginal zone B-cell lymphoma of MALT type. Blood 96: 410-419.